Papers - Hiroko Nishida
-
HDAC inhibition induces CD26 expression on multiple myeloma cells via the c-Myc/Sp1-mediated promoter activation
Hiroko Nishida, Reiko Suzuki, Kiyora Nakajima, Mutsumi Hayashi; Chikao Morimoto, Taketo Yamada
Cancer Research Communications (AACR) 4 ( 2 ) 349 - 364 2024.01
Research paper (scientific journal), Joint Work, Lead author, Accepted
-
Rapid progress in immunotherapies for multiple myeloma: an updated comprehensive review
Hiroko Nishida
Cancers (Basal) 13 ( 11 ) 2712 2021.05
Research paper (scientific journal), Single Work, Accepted
-
Monoclonal antibody therapies in multiple myeloma: a challenge to develop novel targets.
Hiroko Nishida, Taketo Yamada
Journal of Oncology 6084012 1 - 10 2019.11
Research paper (scientific journal), Accepted
-
Novel antibody-drug conjugate with anti-CD26 humanized monoclonal antibody and transcription factor IIH (TFIIH) inhibitor, triptolide, inhibits tumor growth via impairing RNA synthesis.
Mutsumi Hayashi, Hiroko Madokoro, Koji Yamada, Hiroko Nishida, Chikao Morimoto, Michiie Sakamoto, Hiroshi Yanagawa, Taketo Yamada
Cancers (Basal) 11 ( 8 ) 1138 2019.08
Research paper (scientific journal), Accepted
-
CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma.
Hiroko Nishida, Mutsumi Hayashi, Michiie Sakamoto, Chikao Morimoto, Taketo Yamada
Blood Cancer Journal 8 ( 99 ) 1 - 17 2018.10
Research paper (scientific journal), Joint Work, Accepted
-
Primary isolated bone marrow diffuse large B cell lymphoma with long term complete remission
Hiroko Nishida, Hiroshi Suzuki, Masao Hori, Katsuyuki Obara
Leukemia Research Reports 10 11 - 15 2018.07
Research paper (scientific journal), Joint Work, Accepted
-
Bone-targeted agents in multiple myeloma
Hiroko Nishida
Hematology Reports 10 12 - 16 2018.03
Research paper (scientific journal), Single Work, Accepted
-
Bone Targeted Therapy in Multiple Myeloma
Hiroko Nishida
International Journal of Hematological Disorders 3 ( 1 ) 3 - 6 2017.03
Research paper (scientific journal), Single Work, Accepted
-
A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retrated G2/M cell cycle transition.
Mutsumi Hayashi, Hiroko Madokoro, Kohji Yamada, Hiroko Nishida, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
Cancer Cell International. 16 35 2016.04
Research paper (scientific journal), Joint Work, Accepted
-
孤立性中枢神経再発をきたしたII型腸症関連T細胞性リンパ腫
西田浩子、遠藤聖、波多野まみ、立川伸雄、間嶋絵梨、橋田里妙、堀眞佐男、小原克之
臨床血液 56 ( 6 ) 692 - 698 2015.06
Research paper (scientific journal), Joint Work, Accepted
-
Optic Nerve Involvement of Waldenström's Macroglobulinemia - with Autopsy Findings
Hiroko Nishida, Risa Hashida, Mami Hatano, Masao Hori, Katsuyuki Obara
Neurological Sciences 35 ( 8 ) 1299 - 1302 2014.07
Research paper (scientific journal), Joint Work, Accepted
-
Blockade of CD26 Signaling Inhibits Human Osteoclast Development
Hiroko Nishida, Hiroshi Suzuki, Hiroko Madokoro, Mutsumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
Journal of Bone and Mineral Resarch 29 ( 11 ) 2439 - 2455 2014.05
Research paper (scientific journal), Joint Work, Accepted
-
A Report of 2 cases of Disseminated Invasive Aspergillosis with Myocarditis in Immunocompromised Patients
Tetsuhiro Yoshino, Hiroko Nishida, Michihiro Sakauchi, Masanori Nemoto, Mami Hatano, Kazuyuki Koyama, Masao, Hori, Katsuyuki Obara
OJPathology 3 ( 4 ) 166-169 2013.08
Research paper (scientific journal), Joint Work, Accepted, ISSN 2164-6775
-
Nuclear Localization of CD26 Induced by a Humanized Monoclonal Antibody Inhibits Tumor Cell Growth by Modulating of POLR2A Transcription
Kohji Yamada, Mutsumi Hayashi, Hiroko Madokoro, Hiroko Nishida, Wenlin Du, Kei Ohnuma, Michiie Sakamoto, Chikao Morimoto, Taketo Yamada
PLOS ONE 8 ( 4 ) e62304 2013.04
Research paper (scientific journal), Joint Work, Accepted
-
Primary isolated bone marrow diffuse large B‐cell lymphoma with the initial presentation as severe thrombocytopenia, successfully treated with chemotherapy: a case report and review of the literature
Hiroko Nishida, Masao Hori, Katsuyuki Obara
Journal of Cancer Therapeutics ＆ Resarch 28 ( 1 ) 1-7 2012.10
Research paper (scientific journal), Joint Work, Accepted, ISSN 2049-7962
-
Primary B-cell lymphoma of the cauda equina, successfully treated with high-dose methotrexate plus high-dose cytarabine;a case report with MRI findings.
Hiroko Nishida, Masao Hori, Katsuyuki Obara
Neurological Sciences 33 ( 2 ) 403-407 2012.04
Research paper (scientific journal), Joint Work, Accepted
-
Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia
Hiroto Yamazaki, C. Wilson Xu, Motohiko Naito, Hiroko Nishida, Toshihiro Okamoto, Farhana Ishrat Ghani, Satoshi Iwata, Takeshi Inukai, Kanji Sugita, Chikao Morimoto
Biochemical Biophysical Resarch Communinactions 409 ( 1 ) 14-21 2011.05
Research paper (scientific journal), Single Work
-
Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system.
Tauchi T, Kizaki M, Okamoto S, Tanaka H, Tanimoto M, Inokuchi K, Murayama T, Saburi Y, Hino M, Tsudo M, Shimomura T, Isobe Y, Oshimi K, Dan K, Ohyashiki K, Ikeda Y; TARGET Investigators.
Leukemia Resarch 35 ( 5 ) 585-590 2011.05
Research paper (scientific journal), Joint Work
-
Isolation of cancer stem cell-like population by CD90 and CD110 in human T-acute lymphoblastic leukemia
Hiroto Yamazaki, Hiroko Nishida, Satoshi Iwata, Nam H Dang, Takeshi Inukai, Kanji Sugita, Chikao Morimoto
Biochemical and Biophysical Resarch Communications 382 ( 2 ) 172-177 2009.03
Research paper (scientific journal), Joint Work, Accepted
-
CD9 correlates with cancer stem cell potentials in B-acute lymphoblastic leukemia.
Hiroko Nishida, Hiroto Yamazaki, Taketo Yamada, Satoshi Iwata, Nam H Dang, Takeshi Inukai, Kanji Sugita, Yasuo Ikeda, Chikao Morimoto
Biochemical and Biophysical Resarch Communucations 382 ( 1 ) 57-62 2009.02
Research paper (scientific journal), Single Work